34 results
8-K
EX-10.1
YMAB
Y-Mabs Therapeutics Inc
22 Dec 20
Entry into a Material Definitive Agreement
5:15pm
. Within [***] after the Effective Date, the Parties shall establish a Joint Steering Committee (“JSC”) to oversee and coordinate the activities … or revisions to the Joint Development Plan;
(v) review and discuss any clinical protocols relating to the Joint Development Plan;
(vi) oversee
8-K
YMAB
Y-Mabs Therapeutics Inc
19 Feb 21
Y-mAbs Announces Proposed Public Offering of Common Stock
6:01am
ability to oversee the commercialization of DANYELZA or other products, if approved, or development of our product candidates.
If we raise … Service pharmaceutical pricing program;
a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative
10-K
szwtcnp3 wzqf
22 Mar 19
Annual report
4:02pm
DEF 14A
2myf6fssbj8t8zhe9ud
30 Apr 19
Definitive proxy
3:50pm
DRS/A
ntxsyej
8 Jun 18
Draft registration statement (amended)
12:00am
424B5
v5mxvf xgh2z
18 Feb 21
Prospectus supplement for primary offering
5:22pm
10-Q
pltvw1hm7utf760ji1w
13 Nov 18
Quarterly report
9:28am
424B5
bx6ae1x2sidtoah
17 Feb 21
Prospectus supplement for primary offering
6:02am
424B4
6410i6ex c9
21 Sep 18
Prospectus supplement with pricing info
7:33pm